These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19811509)

  • 1. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome.
    Erickson D; Erickson B; Watson R; Patton A; Atkinson J; Meyer F; Nippoldt T; Carpenter P; Natt N; Vella A; Thapa P
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):793-9. PubMed ID: 19811509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas.
    Kasaliwal R; Sankhe SS; Lila AR; Budyal SR; Jagtap VS; Sarathi V; Kakade H; Bandgar T; Menon PS; Shah NS
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):825-30. PubMed ID: 23061773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
    Kaltsas GA; Giannulis MG; Newell-Price JD; Dacie JE; Thakkar C; Afshar F; Monson JP; Grossman AB; Besser GM; Trainer PJ
    J Clin Endocrinol Metab; 1999 Feb; 84(2):487-92. PubMed ID: 10022405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours.
    Stobo DB; Lindsay RS; Connell JM; Dunn L; Forbes KP
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):673-7. PubMed ID: 21609346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Imaging Targeting Corticotropin-releasing Hormone Receptor for Corticotropinoma: A Changing Paradigm.
    Walia R; Gupta R; Bhansali A; Pivonello R; Kumar R; Singh H; Ahuja C; Chhabra R; Singh A; Dhandapani S; Sahoo S; Rana N; Vatsa R; Dutta P; Kumar Bhadada S; Sachdeva N; Mittal BR; Nahar U; Shukla J
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1816-e1826. PubMed ID: 33079979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRH stimulation improves
    Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
    Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease.
    Tabarin A; Laurent F; Catargi B; Olivier-Puel F; Lescene R; Berge J; Galli FS; Drouillard J; Roger P; Guerin J
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):293-300. PubMed ID: 9861318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging diagnostic methods and imaging modalities in cushing's syndrome.
    Wright K; van Rossum EFC; Zan E; Werner N; Harris A; Feelders RA; Agrawal N
    Front Endocrinol (Lausanne); 2023; 14():1230447. PubMed ID: 37560300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome.
    Senanayake R; Gillett D; MacFarlane J; Van de Meulen M; Powlson A; Koulouri O; Casey R; Bashari W; Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101513. PubMed ID: 34045044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential utility of FLAIR in MRI-negative Cushing's disease.
    Chatain GP; Patronas N; Smirniotopoulos JG; Piazza M; Benzo S; Ray-Chaudhury A; Sharma S; Lodish M; Nieman L; Stratakis CA; Chittiboina P
    J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.
    Tsagarakis S; Vassiliadi D; Kaskarelis IS; Komninos J; Souvatzoglou E; Thalassinos N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2080-6. PubMed ID: 17356045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
    Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
    Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cavernous sinus sampling is highly accurate in distinguishing Cushing's disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location.
    Graham KE; Samuels MH; Nesbit GM; Cook DM; O'Neill OR; Barnwell SL; Loriaux DL
    J Clin Endocrinol Metab; 1999 May; 84(5):1602-10. PubMed ID: 10323387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
    Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
    N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging in Cushing's syndrome.
    Sahdev A; Reznek RH; Evanson J; Grossman AB
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1319-28. PubMed ID: 18209870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E; Maiter D; Grandin C; Raftopoulos C
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
    Grober Y; Grober H; Wintermark M; Jane JA; Oldfield EH
    J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.